Commencement of recruitment always good news with any bio-tech as they are invariably tardy on start dates, no matter the individual company. The new management has shown its far more on alert to previous tardiness in trials. Is it really so surprising that it starts in an Australian location? The past is the past, and I don't care, as long as it recruits according to timeframes going forward and the recently accelerated recruitment in the funded phase III trial Sculptor bodes well.
Commencement of recruitment always good news with any bio-tech...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 16.0¢ | $1.021K | 6.379K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 77738 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 3400 | 1 |
View Market Depth
| Last trade - 09.59am 24/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |